Table 2.
HR | 95% CI | |
---|---|---|
Gender Male Female |
Ref 0.90 |
0.78–1.04 |
Age 0–44 years 45–64 years >64 years |
Ref 3.70 10.86 |
3.02–4.52 8.38–14.07 |
Diabetes No Yes |
Ref 1.21 |
1.05–1.41 |
Cardiovascular disease No Yes |
Ref 1.23 |
1.06–1.43 |
KRT transition after first graft failure TX-PD-TX TX-TX TX-HD (no WL) TX-HD (WL) TX-HD-TX TX-PD (no WL) TX-PD (WL) |
Ref 2.80 9.28 7.08 3.71 13.32 5.39 |
0.79–9.93 3.45–25.00 2.62–19.08 1.37–10.01 4.56–38.94 1.77–16.41 |
Functional autonomy Normal/nearly normal Limited Dependent/hospitalized |
Ref 1.48 4.34 |
1.17–1.87 2.89–6.53 |
CI, confidence interval; KRT, kidney replacement therapy; HR, hazard ratio; WL, waiting list.